ArticleIn vivo (Athens, Greece)

Impact of Immune-related Adverse Events on Nivolumab Efficacy in Patients With Upper Gastrointestinal Cancer.

Eisuke Booka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.